Transcripts

Altria (MO) earnings call transcripts

Earnings call transcripts for Altria, with a summary, the guidance given, and what analysts pressed on.

  • Q4 2025 earnings call

    Management framed 2025 as strategic progress amid illicit-market pressure, with core tobacco funding measured smoke-free investment and shareholder returns.

    Jan 29, 2026Mildly positive0.35
  • Q3 2025 earnings call

    Management framed the quarter around resilient core tobacco profits, smoke-free product development and regulatory progress, while emphasizing that consumer demand and competition remain dynamic.

    Oct 30, 2025Positive0.55
  • Q2 2025 earnings call

    Management framed the quarter around resilient core cash generation, ON’s contribution, and regulatory enforcement as prerequisites for smoke-free growth.

    Jul 30, 2025Mildly positive0.35
  • Q1 2025 earnings call

    Management framed the quarter around resilient core tobacco profitability and ON momentum, while stressing that illicit vapes and consumer pressure complicate the smoke-free transition.

    Apr 29, 2025Mildly positive0.25
  • Q3 2023 earnings call

    Management framed the quarter around resilient legacy cash generation funding a smoke-free transition, while stressing illicit vaping’s growing disruption and enforcement gaps.

    Oct 26, 2023Mildly positive0.25
  • Q1 2023 earnings call

    Management framed the quarter as on-plan despite consumer strain, emphasizing targeted brand support, smoke-free growth and regulatory enforcement over broad strategic change.

    Apr 27, 2023Mildly positive0.24
  • Q4 2022 earnings call

    Management framed 2023 around balancing shareholder returns with smoke-free investment, while stressing that macroeconomic uncertainty—not a strategic shift—tempered its outlook.

    Feb 01, 2023Mildly positive0.35